glucagon has been researched along with mitiglinide in 4 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (mitiglinide) | Trials (mitiglinide) | Recent Studies (post-2010) (mitiglinide) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 120 | 30 | 50 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajisawa, Y; Kinukawa, M; Ohnota, H | 1 |
| Hamano, S; Kinukawa, M; Kitamura, T; Miyata, H; Ohnota, H; Shibata, N; Ujiie, A | 1 |
| Inoue, M | 1 |
| Cho, KY; Nakamura, A; Nomoto, H; Ono, Y | 1 |
1 trial(s) available for glucagon and mitiglinide
| Article | Year |
|---|---|
Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glucagon; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged | 2012 |
3 other study(ies) available for glucagon and mitiglinide
| Article | Year |
|---|---|
Effect of a non-sulphonylurea hypoglycaemic agent, KAD-1229 on hormone secretion in the isolated perfused pancreas of the rat.
Topics: Animals; Anti-Bacterial Agents; Glucagon; Glucose; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Pancreas; Rats; Reperfusion; Somatostatin; Streptozocin | 1996 |
A rapid- and short-acting hypoglycemic agent KAD-1229 improves post-prandial hyperglycemia and diabetic complications in streptozotocin-induced non-insulin-dependent diabetes mellitus rats.
Topics: Albuminuria; Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Isoindoles; Male; Pancreas; Rats; Rats, Sprague-Dawley; Streptozocin | 1996 |
The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Breakfast; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period; Triglycerides | 2014 |